Related Experiment Video
Updated: Aug 17, 2026

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
Published on: May 8, 2017
[Actinomycetomas in Senegal: study of 90 cases]
1Service de dermatologie, CHU Le Dantec, BP 3001, Dakar, Sénégal. mftd@sentoo.sn
Abstract:
Mycetoma is a pathological process during which eumycetomic (fungal) or actinomycotic causative agents from exogenous source produce grains. Medical treatment is available for actinomycetomas and surgery is still the main treatment for eumycetoma. We report 90 cases of actinomycetoma occuring in male adult patients coming mainly from central Senegal. Patients living far from health structures consult after a long evolution period for tumors and pains which prevent them from carrying out their activities. The three etiological agents in our patients were Actinomadura pelletieri (60 cases), Actinomadura madurae (25 cases) and Streptomyces somaliensis (5 cases). The three clinical features are inflammatory forms (75 cases) mainly due to Actinomadura pelletieri, tumoral forms (13 cases) and cystic forms (2 cases). Lesions are localized on the foot in 50% of cases and in other part of the body for the other half. Bone damage was observed in 55% of cases. 83% of the patients were cured after a one-year treatment of sulfametoxazole adminstered orally. Two patients died of visceral involvement.
Insights
Actinomycetoma, a fungal infection, commonly affects adult males in Senegal, presenting as tumors or pain. Oral sulfametoxazole achieved an 83% cure rate in a study of 90 patients.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Dermatology
Context:
- Mycetoma is a chronic granulomatous disease caused by fungi or actinomycetes.
- Actinomycetoma, a subtype, is treatable with medication, unlike eumycetoma which often requires surgery.
- This study focuses on actinomycetoma cases in male adults from central Senegal.
Purpose:
- To describe the clinical features, etiological agents, and treatment outcomes of actinomycetoma in a Senegalese population.
- To evaluate the efficacy of sulfametoxazole in treating actinomycetoma.
Summary:
- Ninety male adult patients with actinomycetoma were analyzed.
- The primary causative agents identified were Actinomadura pelletieri (60 cases), Actinomadura madurae (25 cases), and Streptomyces somaliensis (5 cases).
- Clinical presentations included inflammatory (75 cases), tumoral (13 cases), and cystic (2 cases) forms, with lesions frequently on the foot (50%) and associated bone damage (55%).
Impact:
- An 83% cure rate was observed after one year of oral sulfametoxazole treatment.
- The findings highlight sulfametoxazole as an effective treatment for actinomycetoma.
- Two cases resulted in mortality due to visceral involvement, underscoring the potential severity of the disease.
Related Concept Videos
Cryptococcal Meningitis
Rocky Mountain Spotted Fever
Brain Abscess l: Introduction
